ビタミンB6状態と肝繊維症との関連:NHANES 2005-2010からの証拠
Junlu Peng1,2, Wenjun Zhang2, Meng Pan3
1Department of Hepatobiliary Surgery, Shandong Provincial Third Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Frontiers in nutrition
|August 21, 2025
まとめ
ピリドクサル5'- リン酸 (PLP) の高いレベルは,肝繊維症 (LF) のリスクの低下と相関しています. 対照的に,4-ピリドキシ酸 (4-PA) /PLP比が上昇すると,ビタミンB6の代謝が増加し,LFのリスクが高くなります.
科学分野:
- ヘパトロジー
- 栄養学的生化学
- 慢性疾患 の 疫学
背景:
- 肝繊維症 (LF) は,様々な原因による世界的な健康問題です.
- ビタミンB6の代謝は炎症時に変化し,糖尿病や高血圧などの疾患に関連しています.
- ビタミンB6とLFのリスクの関係については,これまで調査されていません.
研究 の 目的:
- ビタミンB6代謝産物 (4-ピリドキシ酸 [4-PA],ピリドクサル5エターフェスファート [PLP]) とその比率が肝臓線維症のリスクとの関連を調査する.
- LFリスクの潜在的バイオマーカーとしてビタミンB6の状態を調査する.
主な方法:
- 国家保健栄養調査 (2005年−2010年) のデータを活用した.
- 4-PAとPLPの血清濃度,および4-PA/PLP比を用いてビタミンB6の状態を評価した.
- ビタミンB6状態とLFとの関連を判定するために,コバリアートに調整し,サブグループ分析を行った.
主要な成果:
- 高血清PLPレベルは,LFのリスクの低下と有意に関連していた (OR=0. 44,p< 0. 001).
- ビタミンB6の代謝が速いことを示す4- PA/ PLP比は,LFのリスクの高さに関連していた (OR=2. 69,p<0. 001).
- 4- PAレベルとLFリスクとの間に有意な関連は観察されなかった.
結論:
- 血清のPLP濃度が高いと,肝繊維症を発症する確率は低下する.
- ビタミンB6代謝の加速を反映した4- PA/ PLP比の増加は,肝繊維症の上昇率と関連しています.
- これらの発見は,肝繊維症の病原性におけるビタミンB6代謝の潜在的な役割を強調しています.
関連する概念動画
Vitamins
989
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
989
Ultrasound II: Endoscopic Ultrasound and FibroScan
198
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
198
Diseases of the Liver and Gallbladder
976
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
976
Hepatic Drug Excretion: Influencing Factors
216
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
216
Liver Physiology
1.2K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.2K


